Genetic Association Studies of Bipolar Disorder

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Association Studies of Bipolar Disorder Genetic Association Studies of Bipolar Disorder Dr Nicholas James Bass This thesis is submitted for the degree of Doctor of Medicine (MD) at University College London 2007 Molecular Psychiatry Laboratory Department of Mental Health Sciences Royal Free and University College London Medical School The Windeyer Institute of Medical Sciences 46 Cleveland Street London W 1T4JF 1 UMI Number: U591560 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U591560 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Statement of Conjoint Work My work was very much part of a team effort. My specific contributions were: 1. UCL bipolar sample collection - recruitment, diagnostic interviewing, blood sampling and data management of 300 bipolar volunteers and over 100 control volunteers. 2. DNA preparation - extraction, quantification and plating out for PCR-based analysis. 3. Marker selection - from literature and using bioinformatic tools. 4. Microsatellite genotyping at BDNF, P2RX7 and COMT loci. 5. Microsatellite genotyping at DISCI locus in conjunction with Cindy Yang. 6. SNP genotyping at BDNF and COMT loci using Taqman, Amplifluor and RFLP assays. 7. Statistical analysis of data. Dr Cindy Yang presented some of the microsatellite data relating to the DISCI locus in her MSc (Molecular Medicine) thesis 2005. O 8/c'i /cy 2 Abstract Bipolar disorder is a common and serious mental illness. The occurrence of mania is central to the diagnosis, but affected individuals typically also suffer episodes of depression. The results of family, twin and adoption studies argue convincingly for genetic susceptibility to bipolar disorder. Linkage studies conducted at the Molecular Psychiatry Laboratory, UCL have previously implicated the regions 12q24, 21q22, lq42 and 11 p 14- 15 as harbouring susceptibly loci for bipolar disorder. In this thesis I report fine mapping of the 12q24, 21q22 and lq42 regions by linkage disequilibrium methods, employing a case-control design. For the llpl4-15 region association with the candidate gene BDNF was tested. I also present attempts to replicate findings of association at the genes DAOA and COMT, located in regions implicated by meta-analysis of the linkage data. I have attempted to put these investigations in context, necessitating consideration of the conceptual developmental of bipolar disorder, the classical techniques for assessing the genetic contribution to aetiology, and mapping strategies. Fine mapping of the UCL linkage regions implicated two novel susceptibility loci and provided support for two previously identified loci. Association of multiple markers within a 180 kb region of 12q24.3 was found, implicating Slynar and LOC387895. Association was also found with two markers in the more centromeric gene P2RX7, previously implicated in a Canadian sample. Multiple associated markers were found on 21q22.3. Two candidate genes - C21orf29 and TRPM2 - were identified from this region. Initial efforts to fine map the lq42 region suggested the involvement of the previously implicated DISCI gene. However association was only found with a single marker. Although haplotypic association was found with BDNF, the complex structure of the microsatellite marker hindered interpretation of the results. Partial replication of the association with DAOA was achieved but the involvement of COMT was not supported. 3 Contents Acknowledgements ...................................................................................................................... ..9 Chapter 1: What is Bipolar Disorder?............................................................................... 10 1.1 Modem conceptualisation .................................................................................................. 10 1.2 Clinical aspects .................................................................................................................... 14 1.3 Is bipolar disorder im portant? ........................................................................................... 15 1.4 Is bipolar disorder treatable? ............................................................................................. 17 1.5 Historical perspective .......................................................................................................... 20 1.6 Sum m ary............................................................................................................................... 24 Chapter 2: Is Bipolar Disorder Genetic?........................................................................... 26 2.1 The problem of phenotype definition .............................................................................. 26 2.2 Evidence for genetic aetiology to bipolar disorder ....................................................... 28 2.2.1 Family studies................................................................................................................ 29 2.2.2 Segregation analysis ..................................................................................................... 31 2.2.3 Twin studies ................................................................................................................... 35 2.2.4 Adoption studies ........................................................................................................... 39 2.3 Summary............................................................................................................................... 40 Chapter 3: Mapping Bipolar Disorder I - Chromosomal Aberrations and Linkage Analysis.................................................................................................................................. 42 3.1 Methods of gene mapping ................................................................................................. 42 3.2 Chromosomal aberrations ................................................................................................. 43 3.3 Linkage .................................................................................................................................. 45 3.3.1 Basic concept ................................................................................................................ 45 3.3.2 Parametric and non-parametric analysis ................................................................... 46 3.3.3 M arkers........................................................................................................................... 48 3.3.4 Linkage findings in bipolar disorder ......................................................................... 49 3.3.5 Review of meta-analyses of bipolar linkage studies .............................................. 53 3.3.6 Homozygosity mapping .............................................................................................. 58 3.4 Summary.............................................................................................................................. 59 Chapter 4: Mapping Bipolar Disorder II - Linkage Disequilibrium Mapping ......... 61 4.1 Basic concept ........................................................................................................................ 61 4.2 LD measures......................................................................................................................... 63 4.3 Study design ......................................................................................................................... 64 4.3.1 Power ............................................................................................................................... 64 4.3.2 Sample groups ............................................................................................................... 66 4.3.3 Populations .................................................................................................................... 68 4.3.4 Markers........................................................................................................................... 69 4.3.5 Haplotype analysis ....................................................................................................... 70 4.3.6 Statistical considerations ............................................................................................. 72 4.3.7 Systematic LD mapping versus candidate gene approach .................................... 73 4.4 Association studies in bipolar disorder ........................................................................... 74 4.4.1 Meta-analysis of association studies ......................................................................... 75 4.4.2 Meta-analysis of 5-HTT association ......................................................................... 76 4.4.3 Meta-analysis of MAO A association ........................................................................ 81 4.4.4 Interpretation of meta-analysis .................................................................................. 84 4 4.5 Genomewide
Recommended publications
  • Developmental Plasticity and Circuit Mechanisms of Dopamine-Modulated Aggression Darshini Mahadevia Submitted in Partial Fulfill
    Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2018 © 2018 Darshini Mahadevia All rights reserved ABSTRACT Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Aggression and violence pose a significant public health concern to society. Aggression is a highly conserved behavior that shares common biological correlates across species. While aggression developed as an evolutionary adaptation to competition, its untimely and uncontrolled expression is maladaptive and presents itself in a number of neuropsychiatric disorders. A mechanistic hypothesis for pathological aggression links aberrant behavior with heightened dopamine function. However, while dopamine hyper-activity is a neural correlate of aggression, the developmental aspects and circuit level contributions of dopaminergic signaling have not been elucidated. In this dissertation, I aim to address these questions regarding the specifics of dopamine function in a murine model of aggressive behavior. In chapter I, I provide a review of the literature that describes the current state of research on aggression. I describe the background elements that lay the foundation for experimental questions and original data presented in later chapters. I introduce, in detail, published studies that describe the clinical manifestation and epidemiological spread, the dominant categories, the anatomy and physiology, and the pharmacology of aggression, with a particular emphasis on the dopaminergic system. Finally, I describe instances of genetic and environmental risk factors impacting aggression, concluding with studies revealing an important role for interactions among genetics, environmental factors, and age in the development of aggression.
    [Show full text]
  • JAD 5478.Pdf
    JAD-05478; No of Pages 9 Journal of Affective Disorders xxx (2012) xxx–xxx Contents lists available at SciVerse ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms Armen K. Goenjian a,b,e,⁎, Julia N. Bailey c,d, David P. Walling b, Alan M. Steinberg a, Devon Schmidt b, Uma Dandekar d, Ernest P. Noble e a UCLA/Duke University National Center for Child Traumatic Stress, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA), United States b Collaborative Neuroscience Network, Garden Grove, CA 92845, United States c Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, United States d Epilepsy Genetics/Genomics Laboratories, VA GLAHS, Los Angeles, CA, United States e Alcohol Research Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, United States article info abstract Article history: Objective: To examine the potential contribution of the serotonin hydroxylase (TPH1 and Received 29 January 2012 TPH2) genes, and the serotonin transporter promoter polymorphism (5HTTLPR) to the unique Accepted 5 February 2012 and pleiotropic risk of PTSD symptoms and depressive symptoms. Available online xxxx Methods: Participants included 200 adults exposed to the 1988 Spitak earthquake from 12 multigenerational families (3 to 5 generations). Severity of trauma exposure, PTSD, and de- Keywords: pressive symptoms were assessed using standard psychometric instruments. Pedigree-based Genetics variance component analysis was used to assess the association between select genes and PTSD the phenotypes. Depression Results: After adjusting for age, sex, exposure and environmental variables, there was a signif- Tryptophan hydroxylase icant association of PTSD symptoms with the ‘t’ allele of TPH1 SNP rs2108977 (pb0.004), Serotonin transporter explaining 3% of the phenotypic variance.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • FROM MELANCHOLIA to DEPRESSION a HISTORY of DIAGNOSIS and TREATMENT Thomas A
    1 FROM MELANCHOLIA TO DEPRESSION A HISTORY OF DIAGNOSIS AND TREATMENT Thomas A. Ban International Network for the History of Neuropsychopharmacology 2014 2 From Melancholia to Depression A History of Diagnosis and Treatment1 TABLE OF CONTENTS Introduction 2 Diagnosis and classifications of melancholia and depression 7 From Galen to Robert Burton 7 From Boissier de Sauvages to Karl Kahlbaum 8 From Emil Kraepelin to Karl Leonhard 12 From Adolf Meyer to the DSM-IV 17 Treatment of melancholia and depression 20 From opium to chlorpromazine 21 Monoamine Oxidase Inhibitors 22 Monoamine Re-uptake Inhibitors 24 Antidepressants in clinical use 26 Clinical psychopharmacology of antidepressants 30 Composite Diagnostic Evaluation of Depressive Disorders 32 The CODE System 32 CODE –DD 33 Genetics, neuropsychopharmacology and CODE-DD 36 Conclusions 37 References 37 INTRODUCTION Descriptions of what we now call melancholia or depression can be found in many ancient documents including The Old Testament, The Book of Job, and Homer's Iliad, but there is virtually 1 The text of this E-Book was prepared in 2002 for a presentation in Mexico City. The manuscript was not updated. 3 no reliable information on the frequency of “melancholia” until the mid-20th century (Kaplan and Saddock 1988). Between 1938 and 1955 several reports indicated that the prevalence of depression in the general population was below 1%. Comparing these figures, as shown in table 1, with figures in the 1960s and ‘70s reveals that even the lowest figures in the psychopharmacological era (from the 1960s) are 7 to 10 times greater than the highest figures before the introduction of antidepressant drugs (Silverman 1968).
    [Show full text]
  • Effects of TPH2 Gene Variation and Childhood Trauma on the Clinical
    Movement disorders J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2019-322636 on 23 June 2020. Downloaded from ORIGINAL RESEARCH Effects of TPH2 gene variation and childhood trauma on the clinical and circuit- level phenotype of functional movement disorders Primavera A Spagnolo ,1 Gina Norato,2 Carine W Maurer,3 David Goldman,4 Colin Hodgkinson,4 Silvina Horovitz,1 Mark Hallett 1 ► Additional material is ABSTRact known about the contribution of genetic factors to published online only. To view, Background Functional movement disorders (FMDs), the pathophysiology of FMD. please visit the journal online (http:// dx. doi. org/ 10. 1136/ part of the wide spectrum of functional neurological Several studies have indicated that positive jnnp- 2019- 322636). disorders (conversion disorders), are common and often family history for FMD is associated with increased associated with a poor prognosis. Nevertheless, little morbidity risk among family members.2 3 However, 1 Human Motor Control is known about their neurobiological underpinnings, large- scale genetic epidemiology studies (eg, twin- Section, Medical Neurology particularly with regard to the contribution of genetic based, family- based, adoption- based and other Branch, National Institute on Nuerological Disorders and factors. Because FMD and stress-related disorders share population-based studies), which have provided a Stroke, National Institutes of a common core of biobehavioural manifestations, we necessary first step in establishing heritability and Health, Bethesda, MD, USA investigated whether variants in stress-related genes exploring genetic interactions in several neuropsy- 2 Office of Biostatistics, National also contributed, directly and interactively with childhood chiatric disorders, have not yet been carried out in Institute on Neurological Disorders and Stroke, National trauma, to the clinical and circuit-level phenotypes of patients with FMD.
    [Show full text]
  • Collated Document Thomas A. Ban
    1 THOMAS A. BAN: THE WERNICKE-KLEIST-LEONHARD TRADITION WITH SPECIAL REFERENCE TO MANIA, MELANCHOLIA AND MANIC-DEPRESSIVE PSYCHOSIS Collated Document Thomas A. Ban This document includes Thomas A. Ban’s five essays on the Wernicke-Kleist-Leonhard tradition with special reference to mania, melancholia and manic-depressive psychosis. It also includes Ernst Franzek’s comment and Ban’s reply to the last essay. The document is now open for a final comment to all INHN members. Thomas A. Ban August 6, 2015 Fundamentals of the Wernicke-Kleist-Leonhard tradition Thomas A. Ban October 22, 2015 Carl Wernicke’s classification of psychoses with special reference to mania, melancholia and manic-depressive psychosis Thomas A. Ban November 12, 2015 Karl Kleist and the deconstruction of Kraepelin’s diagnostic concept of manic- depressive psychosis Thomas A. Ban November 26, 2015 Karl Leonhard and the diagnostic re-evaluation of Emil Kraepelin’s diagnostic concept of manic- depressive psychosis Thomas A. Ban December 3, 2015 Psychopathology, Leonhard’s classification and the deconstruction of Kraepelin’s diagnostic concept of manic-depressive psychosis 2 Ernst Franzek February 18, 2016 Comment on Ban’s Psychopathology, Leonhard’s classification and the deconstruction of Kraepelin’s diagnostic concept of manic- depressive psychosis Thomas A. Ban August 6, 2015 Reply to Franzek’s comment Fundamentals of the Wernicke-Kleist-Leonhard Tradition Thomas A Ban In 1956, Fritz Freyhan, a German born American pioneer of neuropsychopharmacology focused attention on the heterogeneity in responsiveness to neuroleptics in patients with the diagnosis of schizophrenia and called for a pharmacological re-evaluation of Kraepelin’s diagnostic concepts (Bleuler 1911; Freyhan 1956; Kraepelin 1899).
    [Show full text]
  • Retrograde Inhibition by a Specific Subset of Interpeduncular Α5 Nicotinic Neurons Regulates Nicotine Preference
    Retrograde inhibition by a specific subset of interpeduncular α5 nicotinic neurons regulates nicotine preference Jessica L. Ablesa,b,c, Andreas Görlicha,1, Beatriz Antolin-Fontesa,2,CuidongWanga, Sylvia M. Lipforda, Michael H. Riada, Jing Rend,e,3,FeiHud,e,4,MinminLuod,e,PaulJ.Kennyc, Nathaniel Heintza,f,5, and Ines Ibañez-Tallona,5 aLaboratory of Molecular Biology, The Rockefeller University, New York, NY 10065; bDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029; cDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029; dNational Institute of Biological Sciences, Beijing 102206, China; eSchool of Life Sciences, Tsinghua University, Beijing 100084, China; and fHoward Hughes Medical Institute, The Rockefeller University, New York, NY 10065 Contributed by Nathaniel Heintz, October 23, 2017 (sent for review October 5, 2017; reviewed by Jean-Pierre Changeux and Lorna W. Role) Repeated exposure to drugs of abuse can produce adaptive changes nicotine withdrawal, and optical activation of IPN GABAergic cells that lead to the establishment of dependence. It has been shown that is sufficient to produce a withdrawal syndrome, while blockade of allelic variation in the α5 nicotinic acetylcholine receptor (nAChR) gene GABAergic cells in the IPN reduced symptoms of withdrawal (17). CHRNA5 is associated with higher risk of tobacco dependence. In the Taken together these studies highlight the critical role of α5in brain, α5-containing nAChRs are expressed at very high levels in the regulating behavioral responses to nicotine. Here we characterize two subpopulations of GABAergic interpeduncular nucleus (IPN). Here we identified two nonoverlapping Amigo1 Epyc α + α Amigo1 α Epyc neurons in the IPN that express α5: α5- and α5- neu- 5 cell populations ( 5- and 5- ) in mouse IPN that respond α Amigo1 α Epyc differentially to nicotine.
    [Show full text]
  • Understanding the Molecular Mechanisms of Aggression in BALB/C and TPH2-Deficient Mice
    Understanding the molecular mechanisms of aggression in BALB/c and TPH2-deficient mice Citation for published version (APA): Gorlova, A. (2020). Understanding the molecular mechanisms of aggression in BALB/c and TPH2- deficient mice. OneBook.ru. https://doi.org/10.26481/dis.20200305ag Document status and date: Published: 01/01/2020 DOI: 10.26481/dis.20200305ag Document Version: Publisher's PDF, also known as Version of record Please check the document version of this publication: • A submitted manuscript is the version of the article upon submission and before peer-review. There can be important differences between the submitted version and the official published version of record. People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website. • The final author version and the galley proof are versions of the publication after peer review. • The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.
    [Show full text]
  • Electronic Supplementary Material (ESI) for Metallomics
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2018 Uniprot Entry name Gene names Protein names Predicted Pattern Number of Iron role EC number Subcellular Membrane Involvement in disease Gene ontology (biological process) Id iron ions location associated 1 P46952 3HAO_HUMAN HAAO 3-hydroxyanthranilate 3,4- H47-E53-H91 1 Fe cation Catalytic 1.13.11.6 Cytoplasm No NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis dioxygenase (EC 1.13.11.6) (3- [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; response to hydroxyanthranilate oxygenase) cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan (3-HAO) (3-hydroxyanthranilic catabolic process [GO:0006569] acid dioxygenase) (HAD) 2 O00767 ACOD_HUMAN SCD Acyl-CoA desaturase (EC H120-H125-H157-H161; 2 Fe cations Catalytic 1.14.19.1 Endoplasmic Yes long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty 1.14.19.1) (Delta(9)-desaturase) H160-H269-H298-H302 reticulum acid biosynthetic process [GO:0006636] (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1) 3 Q6ZNF0 ACP7_HUMAN ACP7 PAPL PAPL1 Acid phosphatase type 7 (EC D141-D170-Y173-H335 1 Fe cation Catalytic 3.1.3.2 Extracellular No 3.1.3.2) (Purple acid space phosphatase long form) 4 Q96SZ5 AEDO_HUMAN ADO C10orf22 2-aminoethanethiol dioxygenase H112-H114-H193 1 Fe cation Catalytic 1.13.11.19 Unknown No oxidation-reduction process [GO:0055114]; sulfur amino acid catabolic process (EC 1.13.11.19) (Cysteamine
    [Show full text]
  • Bipolar Disorders 100 Years After Manic-Depressive Insanity
    Bipolar Disorders 100 years after manic-depressive insanity Edited by Andreas Marneros Martin-Luther-University Halle-Wittenberg, Halle, Germany and Jules Angst University Zürich, Zürich, Switzerland KLUWER ACADEMIC PUBLISHERS NEW YORK, BOSTON, DORDRECHT, LONDON, MOSCOW eBook ISBN: 0-306-47521-9 Print ISBN: 0-7923-6588-7 ©2002 Kluwer Academic Publishers New York, Boston, Dordrecht, London, Moscow Print ©2000 Kluwer Academic Publishers Dordrecht All rights reserved No part of this eBook may be reproduced or transmitted in any form or by any means, electronic, mechanical, recording, or otherwise, without written consent from the Publisher Created in the United States of America Visit Kluwer Online at: http://kluweronline.com and Kluwer's eBookstore at: http://ebooks.kluweronline.com Contents List of contributors ix Acknowledgements xiii Preface xv 1 Bipolar disorders: roots and evolution Andreas Marneros and Jules Angst 1 2 The soft bipolar spectrum: footnotes to Kraepelin on the interface of hypomania, temperament and depression Hagop S. Akiskal and Olavo Pinto 37 3 The mixed bipolar disorders Susan L. McElroy, Marlene P. Freeman and Hagop S. Akiskal 63 4 Rapid-cycling bipolar disorder Joseph R. Calabrese, Daniel J. Rapport, Robert L. Findling, Melvin D. Shelton and Susan E. Kimmel 89 5 Bipolar schizoaffective disorders Andreas Marneros, Arno Deister and Anke Rohde 111 6 Bipolar disorders during pregnancy, post partum and in menopause Anke Rohde and Andreas Marneros 127 7 Adolescent-onset bipolar illness Stan Kutcher 139 8 Bipolar disorder in old age Kenneth I. Shulman and Nathan Herrmann 153 9 Temperament and personality types in bipolar patients: a historical review Jules Angst 175 viii Contents 10 Interactional styles in bipolar disorder Christoph Mundt, Klaus T.
    [Show full text]
  • Neurodevelopmental Disorders B
    DSM-5 Training for DJJ Clinicians and Staff Preparing for DSM-5 Rajiv Tandon, M.D. Professor Of Psychiatry University of Florida May 12, 2014 Florida Hotel and Conference Center - Orlando 1 1 Disclosure Information NO RELEVANT FINANCIAL CONFLICTS OF INTEREST MEMBER OF THE DSM-5 WORKGROUP ON PSYCHOTIC DISORDERS CLINICIAN AND CLINICAL RESEARCHER 2 2 3 Program Outline • Introduction – Evolution of DSM and Why DSM-5 • Major Changes in DSM-5 – Structure – Content – Implications for Clinical Practice 4 4 What Characteristics Must A Medical Disorder Have? VALIDITY Must define a “Real” entity with distinctive etiology, pathophysiology, clinical expression, treatment, & outcome UTILITY Must be useful in addressing needs of various stakeholders, particularly patients and clinicians Must predict treatment response, guide treatment selection, and predict course and outcome Must be simple and easy to apply RELIABILITY Different groups of people who need to diagnose this condition must be able to do so in a consistent manner 5 5 Validating a Mental Disorder • Approaches to validating diagnostic criteria for discrete categorical mental disorders have included the following types of evidence: – antecedent validators (unique genetic markers, family traits, temperament, and environmental exposure); [ETIOLOGY] – concurrent validators (defined neural substrates, biomarkers, emotional and cognitive processing, symptom similarity); [PATHOPHYSIOLOGY/CLIN.] – and predictive validators (similar clinical course & treatment response [TREATMENT/PROGNOSIS] 6 6
    [Show full text]
  • Patient with Major Endogenous Depressive Episode with Suicide Attempt
    Original Article International Journal of Research - GRANTHAALAYAH ISSN (Online): 2350-0530 May 2021 9(5), 137–144 ISSN (Print): 2394-3629 PATIENT WITH MAJOR ENDOGENOUS DEPRESSIVE EPISODE WITH SUICIDE ATTEMPT 1 1 1 2 3 Mariana Andrut, a Voicu , Adriana Mavlea , Ilinca Vlaicu , Florin Mititelu and Simona Trifu 1Faculty of Psychology and Educational Science, University of Bucharest, Romania 2Alex Obregia” Clinical Hospital for Psychiatry, Bucharest, Romania 3”Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania ABSTRACT Motivation: Suicide is a major psychiatric emergency, men being more inclined to successful suicide, not to attempts and to approach it by abrupt and aggressive means. Objectives: To present a male patient who developed a major depressive episode, in which the reactive component had a signiicant contribution in return for endogeny. The suicide attempt quickly escalated changes in thymic function over several days. Results: The patient corresponds to the age at which major depressive dis- order begins. There remains a clinical discussion between a genuine suicide Received 28 April 2021 attempt, carried out with a plan, internal turmoil, rumination or a parasuicide, Accepted 18 May 2021 in which the person in question needed a change in the ield of consciousness Published 31 May 2021 to try to throw himself in front of the subway. Note the high internal tension, Corresponding Author the absence of the search for alternative solutions, the narcissistic wound, the Simona Trifu, simona.trifu@umfcd .ro endo-psychic vulnerability, the elements of correctness such as structural men- tal rigidity. DOI 10.29121/ granthaalayah.v9.i5.2021.3925 Conclusions: Early responsiveness to medication emphasizes the endoge- Funding: This research received nous potential and the potential of vulnerability, after the approach through no speciic grant from any funding a combination of antidepressants and antipsychotics, the latter developing a agency in the public, commercial, clearer perspective on reality and decisions.
    [Show full text]